Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
- Category
- Analytics
- Pricing
- freemium
- Difficulty
- beginner
Y Combinator batch: Winter 2020
Directory records are starting points for research. Check the official website for current features, pricing and availability. A catalog sync is not a hands-on product review.
Features
- Team Collaboration
Industries
- Healthcare